Coreline Soft and Mint Medical Partner on AI Lung Cancer Screening Integration

Coreline Soft and Mint Medical have announced a partnership to advance AI enabled lung cancer screening, according to a press release. The collaboration follows more than six months of technical integration work and connects Coreline Soft's AVIEW imaging platform with Mint Medical's mint Lesion reporting system.

The integration allows AI detected pulmonary nodules and other findings to be incorporated directly into structured reporting workflows. It supports functions such as Lung-RADS classifications, volume doubling time calculations, and follow-up planning. The workflow links AI powered nodule detection, multi-disease analysis, structured reporting, and longitudinal tracking across multiple sites.

The collaboration is initially focused on Germany, where low dose CT based lung cancer screening became reimbursable under national health insurance in April 2026. The system is designed to meet Germany's requirements for double reading, CAD software use, and GDPR compliant multi-site data management and is intended to scale to other countries with similar screening programs.

Coreline Soft's AVIEW platform has been applied in more than 2.5 million clinical reads across hospitals in 19 countries and is already used in major screening initiatives in Germany, France, and Italy. Through mint Lesion, radiologists can access AI augmented findings within their reporting process, helping standardize data collection and reduce manual workload.